CoChat

Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence

Hampel, Harald, Nisticò, Robert, Seyfried, Nicholas T., Levey, Allan I., Modeste, Erica, Lemercier, Pablo, Baldacci, Filippo, Toschi, Nicola, Garaci, Francesco, Perry, George, Emanuele, Enzo, Valenzuela, Pedro L., Lucia, Alejandro, Urbani, Andrea, Sancesario, Giulia M., Mapstone, Mark, Corbo, Massimo, Vergallo, Andrea, Lista, Simone · 2021 · Ageing Research Reviews
Cited by 144

The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease (AD) is characterized by non-linear, genetic-drivenpathophysiological dynamics with high heterogeneity in biological alterations and disease spatial-temporal progression. Human in-vivo and post-mortem studies point out a failure of multi-level biological networks underlying AD pathophysiology, including proteostasis (amyloid-β and tau), synaptic homeostasis, inflammatory and immune responses, lipid and energy metabolism, oxidative stress. Therefore, a holistic, systems-level approach is needed to fully capture AD multi-faceted pathophysiology. Omics sciences - genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics - embedded in the systems biology (SB) theoretical and computational framework can generate explainable readouts describing the entire biological continuum of a disease. Such path in Neurology is encouraged by the promising results of omics sciences and SB approaches in Oncology, where stage-driven pathway-based therapies have been developed in line with the precision medicine paradigm. Multi-omics data integrated in SB network approaches will help detect and chart AD upstream pathomechanistic alterations and downstream molecular effects occurring in preclinical stages. Finally, integrating omics and neuroimaging data - i.e., neuroimaging-omics - will identify multi-dimensional biological signatures essential to track the clinical-biological trajectories, at the subpopulation or even individual level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.arr.2021.101346

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 80 references

Cited by

See all 144

Metadata

Authors
Hampel, H., Nisticò, R., Seyfried, N. T., Levey, A. I., Modeste, E., Lemercier, P., Baldacci, F., Toschi, N., Garaci, F., Perry, G., Emanuele, E., Valenzuela, P. L., Lucia, A., Urbani, A., Sancesario, G. M., Mapstone, M., Corbo, M., Vergallo, A., & Lista, S.
Venue
Ageing Research Reviews
Publisher
Elsevier BV
Published
2021-08
Volume
69
Pages
101346
ISSN
1568-1637 (ISSN-L)
OpenAlex
W3158340440
Cited by
144
References
80
FWCI
4.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence. https://app.cochat.ai/papers/10.1016/j.arr.2021.101346
The paper
Hampel, H., Nisticò, R., Seyfried, N. T., Levey, A. I., Modeste, E., Lemercier, P., Baldacci, F., Toschi, N., Garaci, F., Perry, G., Emanuele, E., Valenzuela, P. L., Lucia, A., Urbani, A., Sancesario, G. M., Mapstone, M., Corbo, M., Vergallo, A., & Lista, S. (2021). Omics sciences for systems biology in Alzheimer’s disease: State-of-the-art of the evidence. Ageing Research Reviews. https://doi.org/10.1016/j.arr.2021.101346

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.